Related Experiment Video
Updated: Aug 11, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3
X Zhang1, M S Steiner, A Rinaldy
1Department of Urology, University of Tennessee Health Science Center, 956 Court Avenue, Memphis, TN 38163, USA.
Abstract:
A novel gene, pHyde, was recently cloned from Dunning rat prostate cancer cells. A recombinant adenovirus containing pHyde cDNA gene (AdpHyde) was generated to investigate the biological function of pHyde protein. AdpHyde inhibited the growth of human prostate cancer cells. Apoptosis was induced in AdpHyde transduced cells as demonstrated by DAPI (4', 6-diamino-2-phenylindole), TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick and labeling) staining, and flow cytometry assays. Apoptosis was also induced in human xenograft prostate cancer tumors growing in nude mice following treatment with AdpHyde. AdpHyde transduction resulted in a dose-dependent stimulation of caspase-3 activity in DU145 cells which was blocked by DEVD (succinyl-Asp-Glu-Val-Asp-aldehyde) and VAD (benzyloxycarbonyl - Val - Ala - Asp -fluoromethylketone), inhibitors specifically against caspase-3. Moreover, cancer cells that lacked expression of endogenous caspase-3 were not or barely inhibited by pHyde. These results taken together suggest that pHyde inhibits cancer growth by inducing apoptosis through a caspase-3 dependent pathway.
Insights
A novel gene, pHyde, effectively inhibits prostate cancer growth by triggering programmed cell death (apoptosis) through a caspase-3 dependent mechanism. This discovery offers a potential new therapeutic strategy for prostate cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer remains a significant health concern with a need for novel therapeutic targets.
- The identification and characterization of new genes involved in cancer progression are crucial for developing innovative treatments.
Purpose of the Study:
- To investigate the biological function of the novel gene pHyde in prostate cancer.
- To determine the mechanism by which pHyde affects cancer cell growth and survival.
Main Methods:
- Generation of a recombinant adenovirus carrying the pHyde cDNA gene (AdpHyde).
- Assessment of AdpHyde's effect on human prostate cancer cell growth and induction of apoptosis using DAPI, TUNEL staining, and flow cytometry.
- Evaluation of AdpHyde's efficacy in human prostate cancer xenograft models in nude mice.
- Measurement of caspase-3 activity in response to AdpHyde treatment and assessment of pHyde's effect in cells lacking caspase-3 expression.
Main Results:
- AdpHyde significantly inhibited the growth of human prostate cancer cells.
- AdpHyde transduction induced apoptosis in cancer cells, confirmed by multiple assays.
- Treatment with AdpHyde led to apoptosis in human prostate cancer xenografts.
- A dose-dependent increase in caspase-3 activity was observed following AdpHyde transduction, which was inhibited by specific caspase-3 inhibitors.
- pHyde's inhibitory effect was diminished in cancer cells lacking endogenous caspase-3.
Conclusions:
- The novel gene pHyde inhibits prostate cancer growth.
- pHyde induces apoptosis in prostate cancer cells via a caspase-3 dependent pathway.
- pHyde represents a potential therapeutic target for prostate cancer treatment.
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy

